Cargando…

Dual Biologic Therapy for Refractory Crohn's Disease With Perforation in a Patient Declining Surgical Intervention

Dual biologic therapy can improve clinical, biomarker, and endoscopic outcomes in selected patients with refractory Crohn's disease in whom multiple biologics had failed. We presented a patient with refractory Crohn's disease who was admitted for terminal ileal perforation, massive bloody...

Descripción completa

Detalles Bibliográficos
Autores principales:	Le, Puo-Hsien, Chen, Chien-Ming, Kuo, Chia-Jung, Su, Ming-Yao, Chiu, Cheng-Tang, Tsou, Yung-Kuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629729/ https://www.ncbi.nlm.nih.gov/pubmed/37941582 http://dx.doi.org/10.14309/crj.0000000000001203

Ejemplares similares

Vedolizumab combined with surgical resection successfully treated perforating Crohn’s disease with peritoneal space to rectal and vaginal fistulas: a case report
por: Chung, Meng-Wu, et al.
Publicado: (2021)

Vedolizumab in Crohn’s disease with rectal fistulas and presacral abscess: A case report
por: Yeh, Heng, et al.
Publicado: (2021)

Systemic lupus erythematosus complicated by Crohn’s disease with rectovaginal fistula
por: Yeh, Heng, et al.
Publicado: (2021)

Implementation of fecal microbiota transplantation in a medical center for recurrent or refractory Clostridioides difficile infection and report of preliminary outcome
por: Yeh, Yuan-Ming, et al.
Publicado: (2022)

Rescue therapy with rifabutin regimen for refractory Helicobacter pylori infection with dual drug-resistant strains
por: Kuo, Chia-Jung, et al.
Publicado: (2020)

Endoscopic Resection of Residual or Recurrent Lesions after Circumferential Radiofrequency Ablation for Flat Superficial Esophageal Squamous Cell Neoplasias
por: Tsou, Yung-Kuan, et al.
Publicado: (2023)

Synchronous Head and Neck Cancer and Superficial Esophageal Squamous Cell Neoplasm: Endoscopic Treatment or No Treatment for the Superficial Esophageal Neoplasm
por: Liu, Chung-Wei, et al.
Publicado: (2023)

Fecal microbiota transplantation for treatment of refractory or recurrent Clostridioides difficile infection in Taiwan: a cost-effectiveness analysis
por: Lan, Kai-Yen, et al.
Publicado: (2023)

Fecal microbiota transplantation and donor screening for Clostridioides difficile infection during COVID-19 pandemic
por: Chiu, Cheng-Hsun, et al.
Publicado: (2021)

cT1N0M0 Esophageal Squamous Cell Carcinoma Invades the Muscularis Mucosa or Submucosa: Comparison of the Results of Endoscopic Submucosal Dissection and Esophagectomy
por: Wang, Ching-Ya, et al.
Publicado: (2022)

Risk Factors, Clinical and Endoscopic Features, and Clinical Outcomes in Patients with Cytomegalovirus Esophagitis
por: Yeh, Pai-Jui, et al.
Publicado: (2022)

Pancolitis associated with higher mortality risk of cytomegalovirus colitis in patients without inflammatory bowel disease
por: Le, Puo-Hsien, et al.
Publicado: (2018)

Cytomegalovirus Diseases of the Gastrointestinal Tract
por: Yeh, Pai-Jui, et al.
Publicado: (2022)

Perforating and nonperforating indications in repeated surgeries for Crohn’s disease
por: Shen, Wei-Song, et al.
Publicado: (2022)

Clinical manifestations, risk factors, and prognostic factors of cytomegalovirus enteritis
por: Yeh, Pai-Jui, et al.
Publicado: (2021)

Clinical characteristics of cytomegalovirus colitis: a 15-year experience from a tertiary reference center
por: Le, Puo-Hsien, et al.
Publicado: (2017)

Ustekinumab and Vedolizumab Dual Biologic Therapy in the Treatment of Crohn's Disease
por: Liu, Eddie Y., et al.
Publicado: (2017)

Application of Argon Plasma Coagulation for Gastrointestinal Angiodysplasia in Children— Experience From a Tertiary Center
por: Yeh, Pai-Jui, et al.
Publicado: (2022)

Efficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections
por: Kuo, Chia-Jung, et al.
Publicado: (2019)

Dual Biologic Therapy in an Adolescent With Camurati-Engelmann Disease and Crohn Disease
por: Sami, Ahmad Salah, et al.
Publicado: (2022)

The Temporal Relationships and Associations between Cutaneous Manifestations and Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study
por: Hung, Yi-Teng, et al.
Publicado: (2021)

A Review of the Impact of Biologics on Surgical Complications in Crohn's Disease
por: Chang, Melissa I., et al.
Publicado: (2015)

Biologics and surgical outcomes in Crohn’s disease: is there a direct relationship?
por: Quaresma, Abel Botelho, et al.
Publicado: (2020)

The effect of prophylactic hemoclip placement and risk factors of delayed post-polypectomy bleeding in polyps sized 6 to 20 millimeters: a propensity score matching analysis
por: Chen, Chun-Wei, et al.
Publicado: (2020)

Ustekinumab is effective in biological refractory Crohn’s disease patients–regardless of approval study selection criteria
por: Saman, Sadik, et al.
Publicado: (2019)

Safety of dual biological therapy in Crohn’s disease: a case series of vedolizumab in combination with other biologics
por: Mao, Eric J, et al.
Publicado: (2018)

Managing refractory Crohn’s disease: challenges and solutions
por: Tanida, Satoshi, et al.
Publicado: (2015)

Fecal microbiota transplantation for refractory Crohn's disease
por: Bak, Seon Ho, et al.
Publicado: (2017)

Neonatal gastric perforation: a report of two cases and a systematic review
por: Chen, Tsung-Yen, et al.
Publicado: (2018)

Genetic Variants Associated With Subjective Cognitive Decline in Patients With Migraine
por: Yeh, Po-Kuan, et al.
Publicado: (2022)

Combined use of high doses of vasopressin and corticosteroids in a patient with Crohn’s disease with refractory septic shock after intestinal perforation: a case report
por: Notaro, Salvatore, et al.
Publicado: (2017)

Refractory Duodenal Crohn's Disease Successfully Treated with Infliximab
por: Kim, You Lim, et al.
Publicado: (2014)

Ustekinumab for Successful Treatment of Refractory Esophageal Crohn’s Disease
por: Barkin, Jodie A., et al.
Publicado: (2016)

Case–Control Study of Clostridium innocuum Infection, Taiwan
por: Chen, Yi-Ching, et al.
Publicado: (2022)

Biologic therapy for Crohn’s disease over the last 3 decades
por: Shen, Ji-Liang, et al.
Publicado: (2022)

Esophageal stenting with minimally-invasive surgical intervention for delayed spontaneous esophageal perforation
por: Chiu, Chien-Hung, et al.
Publicado: (2023)

Perforated viscus as first presentation of Crohn’s disease: a case report
por: Lee, Jia Hui, et al.
Publicado: (2021)

Perforated ileum as the initial presentation of Crohn's disease, a case report
por: Tadesse, Robel, et al.
Publicado: (2022)

Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
por: Lin, Chin-Hsien, et al.
Publicado: (2017)

Ages of hepatocellular carcinoma occurrence and life expectancy are associated with a UGT2B28 genomic variation
por: Le, Puo-Hsien, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p2kepe66t1lfo35fkpn1mbe5bf